Legend Biotech Corporation
LEGN
$32.80
-$0.66-1.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -177.03M | -348.13M | -285.01M | -465.95M | -518.25M |
| Total Depreciation and Amortization | 21.59M | 19.90M | 19.41M | 19.04M | 18.56M |
| Total Amortization of Deferred Charges | 1.77M | 2.02M | 2.20M | 1.96M | 1.90M |
| Total Other Non-Cash Items | -10.49M | 78.64M | 15.97M | 139.67M | 175.85M |
| Change in Net Operating Assets | 20.12M | 89.97M | 104.80M | 66.74M | -71.32M |
| Cash from Operations | -144.03M | -157.60M | -142.63M | -238.54M | -393.28M |
| Capital Expenditure | -14.11M | -16.07M | -19.38M | -22.06M | -20.08M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -53.00K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -836.44M | -339.12M | -873.96M | -297.29M | 112.87M |
| Cash from Investing | -850.54M | -355.19M | -893.34M | -319.39M | 92.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.02M | -2.78M | -3.34M | -3.70M | -3.76M |
| Issuance of Common Stock | 9.72M | 9.73M | 7.01M | 796.46M | 795.25M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.70M | 6.96M | 3.67M | 792.77M | 791.49M |
| Foreign Exchange rate Adjustments | -2.09M | 1.64M | 336.00K | 2.69M | 682.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -990.96M | -504.19M | -1.03B | 237.52M | 491.68M |